ATLASCitius Pharmaceuticals (CTXR) earnings date: Dec 22, 2026
Citius Pharmaceuticals (CTXR) reports earnings for the quarter ended Sep 30, 2026 on Tue, Dec 22, 2026. Analysts expect EPS of -$0.41.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on CTXR
| Last price | $0.55 (+4.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±5.5% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Citius Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Citius Pharmaceuticals reports on Dec 22, 2026. One email the day before, with ATLAS’s read on Citius Pharmaceuticals. You can switch it off at any time.
Alert me before CTXR reportsFree to start. Creating an account takes under a minute.
Notify me when Citius Pharmaceuticals reports
Track CTXR free Add Citius Pharmaceuticals to a free ATLAS watchlist and see its next report date in one place.
CTXR earnings at a glance
| Next report (confirmed) | Tue, Dec 22, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.41 |
| Last report | Aug 14, 2026 · Beat |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -41.5% |
| Average move around a report | ±12.3% (last 5) |
| Sector | Healthcare · Biotechnology |
Citius Pharmaceuticals earnings history: last 5 reports
Citius Pharmaceuticals last reported on Aug 14, 2026: EPS of -$0.34 against an estimate of -$0.36 (+5.6% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 14, 2026 | -$0.36 | -$0.34 | +5.6% | Beat | -23.4% |
| Jun 16, 2026 | $1.65 | $1.67 | +1.2% | In line | 0.0% |
| May 15, 2026 | -$0.32 | -$0.95 | -196.9% | Miss | -26.8% |
| Apr 14, 2026 | $0.44 | $0.48 | +9.1% | Beat | +5.0% |
| Feb 13, 2026 | -$0.30 | -$0.38 | -26.7% | Miss | -6.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for CTXR
See the fair value, the probability range and the earnings history of Citius Pharmaceuticals on its ATLAS page.
Citius Pharmaceuticals (CTXR) stock analysisPlans from €3.99 a month.
Citius Pharmaceuticals earnings: frequently asked questions
When does Citius Pharmaceuticals (CTXR) report earnings?
Citius Pharmaceuticals is scheduled to report on Tuesday, December 22, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for CTXR?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.41 per share (USD). Estimates can change before the report.
How often does CTXR beat earnings estimates?
Of its last 5 reports with a recorded result, Citius Pharmaceuticals beat the EPS estimate 2 times; the average surprise was -41.5%. Past results do not predict the next one.
How much does CTXR move around earnings?
Over its last 5 reports the stock moved an average of 12.3% (absolute, from the close before the report day to the close after it), and finished higher 1 of 5 times.
Did Citius Pharmaceuticals beat earnings estimates last quarter?
Citius Pharmaceuticals last reported on Aug 14, 2026: EPS of -$0.34 against an estimate of -$0.36 (+5.6% surprise), a beat.
How much does CTXR usually move in a day?
On a normal trading day the ATLAS model puts CTXR’s one-day range at about ±5.5%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Dec 22, 2026
Educational information, not investment advice. Disclaimer